ClinicalTrials.gg
CompletedNCT03873480Updated Sep 19, 2022

Trigger Thumb Randomized Controlled Trial

An interventional study of Administration of Marcaine without Epinephrine prior to the start of surgery in Trigger Thumb, sponsored by Children's Hospital of Philadelphia. Completed at 1 site in United States. Open to participants aged 0 Years to 4 Years. Per ClinicalTrials.gov, last updated 2022-09-19.

Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Oct 2018, registered Mar 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
0 Years to 4 Years
Sex
All
01

Study summary

We are conducting this study to determine if administration of local anesthetic to the thumb prior to surgery can reduce the amount of anesthetic gas given during the course of surgery.

02

Conditions studied

  • Trigger Thumb
03

In context

Trigger Finger Disorder

93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.

This study's enrollment of 31 is below the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.

Browse Trigger Finger Disorder studies →

Lead sponsor

Children's Hospital of Philadelphia is the lead sponsor of 489 studies on the registry; 90 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 4 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Males or females, age 0-4 years, presenting to the Children's Hospital of Philadelphia (CHOP) Department of Orthopaedics with unilateral trigger thumb that requires surgical treatment.
  2. American Society of Anaesthesiologists (ASA) Classification of 1 or 2.
  3. Parental/guardian permission ().

Exclusion criteria

Exclusion Criteria:

  1. Males or females over the age of 4.
  2. ASA Classification higher than 2.
  3. Patients presenting with systemic diseases or significant comorbidities.
  4. Patients that received treatment for trigger thumb at an outside institution.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Active comparator
    Intervention Arm

    Participants randomized into the intervention group will receive an injection of 2.5 cc of 0.25% marcaine without epinephrine prior to the incision. The local anesthetic will be administered by the treating surgeon. All other aspects of the procedure will be kept in accordance with the standard of care for trigger thumb surgeries.

    Procedure: Administration of Marcaine without Epinephrine prior to the start of surgery

  • No intervention
    Non-Intervention Arm

    Those that are not randomized into the intervention group will receive the standard of care for a trigger thumb release, which is administration of 2.5 cc of 0.25% marcaine without epinephrine following completion of surgery. The local anesthetic will be administered by the treating surgeon.

Interventions

  • ProcedureAdministration of Marcaine without Epinephrine prior to the start of surgery

    The intervention is the timing of administration of marcaine without epinephrine during a trigger thumb surgery.

06

What researchers measure

Primary outcomes

  1. Difference in administered anesthesia

    The primary outcome will be the difference in administered gaseous sevoflurane during the course of trigger thumb surgery between the control group and intervention group.

    Time frame: 3 years

Secondary outcomes

  1. Difference in observed pain score

    The secondary outcome will be the difference in observed pain scores during the post-operative period following a trigger thumb surgery between the control group and intervention group. The FLACC (face, legs, activity, consolability) Behavioural pain scale will be used. There are 5 components, e.g. face, legs, activity, cry, and consolability, that are given a grade of 0, 1, or 2. The sum of the each component grade will give the pain scale score. 0 = Relaxed and comfortable 1-3 = Mild discomfort 4-6 = Moderate pain 7-10 = Severe discomfort/pain

    Time frame: 3 years

  2. Difference in operative time

    The secondary outcome will be the difference in operative time during the course of a trigger thumb surgery between the control group and intervention group.

    Time frame: 3 years

  3. Difference in length of stay

    The secondary outcome will be the difference in total length of study following a trigger thumb surgery between the control group and intervention group.

    Time frame: 3 years

  4. Difference in complication rates

    The secondary outcome will be the difference in complication rates following a trigger thumb surgery between the control group and intervention group.

    Time frame: 3 years

07

Study locations

1 site
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania 19104, United States
08

References and documents

Individual participant data

Plan to share: No — Deidentified individual participant data will not be made available.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03873480
Responsible party
Sponsor
First posted
Mar 13, 2019
Start date
Oct 2, 2018
Primary completion
Nov 10, 2020
Completion
Nov 10, 2020
Last update
Sep 19, 2022

Study contacts

Apurva S Shah, MD, MBA
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion